Journals / Turkish Journal of Gastroenterology / 2017 / Cilt: 28 - Sayı: 3

Can C-reactive protein levels increase the accuracy of the Ranson score in predicting the severity and prognosis of acute pancreatitis? A prospective cohort study

Pages
207–213
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: With the use of our new model, C-reactive-protein levels increase the efficacy of the Ranson score for predicting the severity of AP.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Acute pancreatitis (AP) is an acute inflammatory disorder of the pancreas, and its severe form affects nearly all systems of the body.
📊
Key Findings & Data:Four groups of criteria sets were created: Group 1: Ranson >=3; Group 2: C-reactive-protein >=150 mg/L; Group 3: Ranson >=3 and C-reactive-protein >=150 mg/L; Group 4: Ranson >=3 or C-reactive-protein >=150 mg/L.
💡
Conclusion & Impact:Conclusion: With the use of our new model, C-reactive-protein levels increase the efficacy of the Ranson score for predicting the severity of AP.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Acute pancreatitis (AP) is an acute inflammatory disorder of the pancreas, and its severe form affects nearly all systems of the body. The purpose of this study is to assess the Ranson score and the Creactive-protein level as a novel model for prediction of the disease severity and mortality. Materials and Methods: A prospective cohort study was designed to evaluate the efficacy of the C-reactiveprotein for the prediction of severe AP. We recorded the Ranson score and C-reactive-protein values in AP patients and determined the severity of the disease using the revised Atlanta classification. Four groups of criteria sets were created: Group 1: Ranson >=3; Group 2: C-reactive-protein >=150 mg/L; Group 3: Ranson >=3 and C-reactive-protein >=150 mg/L; Group 4: Ranson >=3 or C-reactive-protein >=150 mg/L. Identification of AP severity was accepted as the reference parameter for statistical analysis. Categorical variables were expressed as frequencies and percentages. The differences were considered as significant if the p value <0.05.Results: Six hundred and thirty-eight patients with AP were included in our study. We recovered a statistically significant difference in our assessment of the prediction of the severity of AP among the various groups (p=0.001). Our analysis revealed that group 4 had the highest sensitivity of 90.1% and 93.5% to differentiate moderately severe and severe AP from mild AP, respectively. Group 3 had the highest specificity of 97.1% for both moderately severe and severe AP. Conclusion: With the use of our new model, C-reactive-protein levels increase the efficacy of the Ranson score for predicting the severity of AP.

🔖

Cite This Article

BAŞAK, F., HASBAHÇECİ, M., ŞİŞİK, A., ACAR, A., TEKEŞİN, K., BAŞ, G., ALİMOĞLU, O. (2017). Can C-reactive protein levels increase the accuracy of the Ranson score in predicting the severity and prognosis of acute pancreatitis? A prospective cohort study. Turkish Journal of Gastroenterology, Cilt: 28 - Sayı: 3, 207–213. https://ajindex.com/articles/410698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-90. [CrossRef ] Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pan- creatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-11. [CrossRef ] Heinrich S, Schäfer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 2006; 243: 154-68. [CrossRef ] Birgisson H, Möller PH, Birgisson S, et al. Acute pancreatitis: a pro- spective study of its incidence, aetiology, severity, and mortality in Iceland. Eur J Surg 2002; 168: 278-82. [CrossRef ] de Beaux AC, Palmer KR, Carter DC. Factors influencing morbidity and mortality in acute pancreatitis: an analysis of 279 cases. Gut 1995; 37: 121-6. [CrossRef ] Chatzicostas C, Roussomoustakaki M, Vlachonikolis IG, et al. Com- parison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitis. Pancreas 2002; 25: 331-5. [CrossRef ] Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prog- nostic signs and the role of operative management in acute pan- creatitis. Surg Gynecol Obstet 1974; 139: 69-81.
  2. De Bernardinis M, Violi V, Roncoroni L, Boselli AS, Giunta A, Perac- chia A. Discriminant power and information content of Ranson's prognostic signs in acute pancreatitis: a meta-analytic study. Crit Care Med 1999; 27: 2272-83. [CrossRef ] Gomatos IP, Xiaodong X, Ghaneh P, et al. Prognostic markers in acute pancreatitis. Expert Rev Mol Diagn 2014; 14: 333-46. [CrossRef] Balthazar EJ. Acute pancreatitis: assessment of severity with clini- cal and CT evaluation. Radiology 2002; 223: 603-13. [CrossRef ] Block S, Maier W, Bittner R, Büchler M, Malfertheiner P, Beger HG. Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut 1986; 27: 1035- 42. [CrossRef ] Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet 2008; 371: 143-52. [CrossRef ] Johnson CD, Toh SK, Campbell MJ. Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of se- vere acute pancreatitis. Pancreatology 2004; 4: 1-6. [CrossRef ] Banks PA, Freeman ML. Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101: 2379-400. [Cro